Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients
Clinical trial NCT02390869 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02390869
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2023-01-25
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.